As of 2025-09-17, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 17.10 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 699.2%.
The range of the Relative Valuation is 8.90 - 26.17 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 22.2x | 18.0x |
| Forward P/E multiples | 14.1x - 19.5x | 16.8x |
| Fair Price | 8.90 - 26.17 | 17.10 |
| Upside | 315.8% - 1122.9% | 699.2% |
| Date | P/E |
| 2025-09-15 | 5.74 |
| 2025-09-12 | 4.94 |
| 2025-09-11 | 4.93 |
| 2025-09-10 | 4.94 |
| 2025-09-08 | 4.94 |
| 2025-09-05 | 4.67 |
| 2025-09-04 | 4.73 |
| 2025-09-02 | 4.77 |
| 2025-08-28 | 4.76 |
| 2025-08-20 | 4.91 |
| 2025-08-19 | 4.90 |
| 2025-08-11 | 4.93 |
| 2025-08-08 | 4.91 |
| 2025-08-06 | 4.91 |
| 2025-08-01 | 4.91 |
| 2025-07-22 | 5.68 |
| 2025-07-18 | 5.70 |
| 2025-07-17 | 5.68 |
| 2025-07-16 | 5.74 |
| 2025-07-14 | 5.76 |
| 2025-07-10 | 5.47 |
| 2025-07-09 | 5.62 |
| 2025-07-08 | 5.00 |
| 2025-07-03 | 4.62 |
| 2025-07-02 | 4.46 |
| 2025-07-01 | 3.63 |
| 2025-06-27 | 4.47 |
| 2025-06-25 | 4.16 |
| 2025-06-24 | 4.23 |
| 2025-06-23 | 4.30 |
| 2025-06-20 | 4.43 |